2019 Papillary Renal Cell Carcinoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 59 pages | ID: 2BCF4755C7DEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Papillary Renal Cell Carcinoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Papillary Renal Cell Carcinoma. It presents in-depth analysis of Papillary Renal Cell Carcinoma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Papillary Renal Cell Carcinoma.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Papillary Renal Cell Carcinoma clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Papillary Renal Cell Carcinoma

The research work is prepared through extensive and continuous research on Papillary Renal Cell Carcinoma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Papillary Renal Cell Carcinoma patients are identified
• The report includes panorama of Papillary Renal Cell Carcinoma clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Papillary Renal Cell Carcinoma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Papillary Renal Cell Carcinoma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Papillary Renal Cell Carcinoma Clinical Trials by Region
  2.2.2 Average Enrollment of Papillary Renal Cell Carcinoma Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Papillary Renal Cell Carcinoma Treatment, 2019

3. REGION WISE PAPILLARY RENAL CELL CARCINOMA CLINICAL TRIALS

3.1 Asia Pacific Papillary Renal Cell Carcinoma Clinical Trials by Country
3.2 Europe Papillary Renal Cell Carcinoma Clinical Trials by Country
3.3 North America Papillary Renal Cell Carcinoma Clinical Trials by Country
3.4 Middle East and Africa Papillary Renal Cell Carcinoma Clinical Trials by Country
3.5 South and Central America Papillary Renal Cell Carcinoma Clinical Trials by Country

4. PAPILLARY RENAL CELL CARCINOMA CLINICAL TRIAL TRENDS

4.1 Start Year wise Papillary Renal Cell Carcinoma Clinical Trials
4.2 Phase wise Papillary Renal Cell Carcinoma Clinical Trials
4.3 Trial Status wise Papillary Renal Cell Carcinoma Clinical Trials
4.4 Trial Type wise Papillary Renal Cell Carcinoma Clinical Trials

5. PAPILLARY RENAL CELL CARCINOMA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Papillary Renal Cell Carcinoma Trials by Year
5.2 Average Enrollment in Papillary Renal Cell Carcinoma Trials by Phase
5.3 Average Enrollment in Papillary Renal Cell Carcinoma Trials by Status
5.4 Average Enrollment in Papillary Renal Cell Carcinoma Trials by Type of Trial

6. COMPANIES PARTICIPATING IN PAPILLARY RENAL CELL CARCINOMA CLINICAL TRIALS

6.1 Papillary Renal Cell Carcinoma Trials by Sponsor Type
6.2 Papillary Renal Cell Carcinoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Papillary Renal Cell Carcinoma Trials- Phase
7.2 Papillary Renal Cell Carcinoma Trials- Phase
7.3 Papillary Renal Cell Carcinoma Trials- Phase
7.4 Papillary Renal Cell Carcinoma Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Papillary Renal Cell Carcinoma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Figure 5: Europe – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Figure 7: North America – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Figure 9: Papillary Renal Cell Carcinoma Clinical Trials by Phase
Figure 10: Papillary Renal Cell Carcinoma Clinical Trials by Trial Status
Figure 11: Papillary Renal Cell Carcinoma Clinical Trials by Type
Figure 12: Papillary Renal Cell Carcinoma Clinical Trials by Sponsor Type
Figure 13: Papillary Renal Cell Carcinoma Clinical Trials by Leading Sponsors
Figure 14: Papillary Renal Cell Carcinoma Average Enrollment by Phase
Figure 15: Papillary Renal Cell Carcinoma Average Enrollment by Trial Status
Figure 16: Papillary Renal Cell Carcinoma Average Enrollment by Type
Figure 17: Papillary Renal Cell Carcinoma- Average Enrolment by Type of Sponsors
Figure 18: Papillary Renal Cell Carcinoma- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Papillary Renal Cell Carcinoma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Table 5: Europe – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Table 7: North America – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Papillary Renal Cell Carcinoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Papillary Renal Cell Carcinoma Average Enrollment by Phase
Table 15: Papillary Renal Cell Carcinoma Average Enrollment by Trial Status
Table 16: Papillary Renal Cell Carcinoma Average Enrollment by Type
Table 17: Papillary Renal Cell Carcinoma- Average Enrolment by Type of Sponsors
Table 18: Papillary Renal Cell Carcinoma- Enrolment by Leading Sponsors